The Role of Activated Monocyte IFN/SIGLEC1 Signalling in Graves' Disease. Wang Y, Jin Z, Sun J, Chen X, et al. J Endocrinol 2022 Jun 1. pii: JOE-21-0453. doi: 10.1530/JOE-21-0453.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Jin Z, Sun J, Chen X, et al. The Role of Activated Monocyte IFN/SIGLEC1 Signalling in Graves' Disease. J Endocrinol 2022 Jun 1. pii: JOE-21-0453. doi: 10.1530/JOE-21-0453.
PMID: 35695299